Rare Tumours News

The 2020 WHO Classification of Soft Tissue Tumours: news ...

Nov 03, 2020 · The label atypical spindle cell lipomatous tumour represents a new name for the entity formerly known as spindle cell liposarcoma 21,22 and at the time of first description regarded as a variant of well differentiated liposarcoma. The entity is now defined as an ill-circumscribed, moderately atypical spindle cell tumour featuring the presence of a variable …

Rare Disease Database - NORD (National Organization for ...

Perlman syndrome is an extremely rare genetic disorder due to recessive mutations in the DIS3L2 gene located on chromosome 2q37.1. Perlman syndrome is characterized by overgrowth before and after birth (macrosomia), distinctive facial features, abnormally enlarged internal organs (organomegaly), the presence of fragments (rests) of embryonic ...

Desmoid Tumor - National Cancer Institute

Category: Treatment

Desmoid tumors grow from the connective tissue in your body. Desmoid tumors are benign, which means they are not cancer, but they are very difficult to get rid of and can be painful to live with. Learn more about diagnosis, treatments, and prognosis for desmoid tumors.

Drug shrinks ovarian tumours in early trial - BBC News

Category: Drugs

Jun 03, 2017 · ONX-0801 is the first in a new class of drugs which work by mimicking the ability of folic acid selectively to latch on to cancer cells, while leaving healthy tissue alone, thus …

Germ cell tumours | Cancer Research UK

Ovarian germ cell tumours . Women can develop ovarian germ cell tumours. Many of these are non cancerous (benign). But some are cancerous. Only about 1 or 2% of ovarian cancers are this type. Most ovarian germ cell tumours occur in teenagers or young women, although they also occur in women in their 60s.

Neuroendocrine tumours | Cancer Council

Category: Disease

Causes of neuroendocrine tumours. The causes of most neuroendocrine tumours are not known. Some risk factors may include: genetic factors – some rare inherited diseases can put people at more risk of developing neuroendocrine tumours pre …

Neuroendocrine tumours (NETs) | Cancer Research UK

Neuroendocrine tumours . Neuroendocrine tumours (NETs) are rare tumours that develop in cells of the neuroendocrine system. They are also called neuroendocrine neoplasms (NENs). There are a number of different types. The type you have depends on the particular cells that the tumour starts in. Some types of NETs are also called carcinoid tumours.

Health: news and advice - Mirror Online

Get the latest news, sport, celebrity gossip, TV, politics and lifestyle from The Mirror. Big stories with a big heart, always with you in mind.

SynOx Therapeutics

Category: Treatment

SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of tenosynovial giant cell tumours (TGCT) and other macrophage-driven pathologies.

Carcinoid Syndrome - NORD (National Organization for Rare ...

Carcinoid tumors are well-differentiated neuroendocrine tumours with secretory properties, releasing serotonin, along with a number of other active peptides. These tumors can arise anywhere along the primitive gut and are therefore found in the bronchial tree (airways) and along the gastrointestinal tract.

Top Categories

Most Popular

Top Search